Under doctor's orders

Sir Christopher Gent, chairman of Reform, the independent think-tank, let slip about his health when expounding policy for choice in healthcare last week. When challenged by a diabetic claiming that choice did not work, Gent responded: "As someone who could well be going down the same road as you…".

A musical mobile phone in the audience interrupted the former Vodafone boss, but as Gent is now chairman of GlaxoSmithKline, should we expect to see R&D diverted to this problem?

WSJ Logo
Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With TrumpExternal link

Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With Trump